Evidence map›Paper›PMID 35464329›Full record

ArticleJournal of medical cases2022

Amphetamine Use Revealing Hypertrophic Cardiomyopathy in a Young Patient.

Vulnet Misimi, Muhemin Mohammed, Konstantinos Stamou, Andreas Mitsis, Panagiotis Sakellaropoulos, Despoina Tounissidou, Stefanos G Sakellaropoulos

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vulnet MisimiDepartment of Internal Medicine, Stadtspital Waid und Triemli, Zurich, Switzerland.
Muhemin MohammedSwiss Cardiovascular Centre, Bern University Hospital, Bern, Switzerland.
Konstantinos StamouSchool of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Andreas MitsisCardiology Department, Nicosia General Hospital, Nicosia, Cyprus.
Panagiotis SakellaropoulosDepartment of Biopathology and Medical Biochemistry, Kalamata General Hospital, Kalamata, Greece.
Despoina TounissidouDepartment of Pediatrics, Kalamata General Hospital, Kalamata, Greece.
Stefanos G SakellaropoulosSwiss Cardiovascular Centre, Bern University Hospital, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenergic overstimulation in long term can lead to a hyperdynamic myocardium and give rise to hypertrophy and ultimately to heart failure. Amphetamine use is a common cause of neurohormonal activation, which gives rise to such adverse cardiovascular events. However, hypertrophy of myocardium in young patients, even due to apparently obvious causes, should always be considered as a red flag and a further diagnostic downstream should take place, in order to exclude genetic causes. We present a case of a young man with chronic use of amphetamine and an incidental finding of hypertrophic cardiomyopathy.

Indexed as

Cardiac MRIHypertrophic cardiomyopathyMyopericarditisSudden cardiac death

Identifiers

PMID35464329
PMCPMC8993442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.